Awareness Level About Cervical Cancer, Human Papillomavirus (HPV) and Corresponding Vaccine Among Women Living in the Western Region of Saudi Arabia

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2023 May 16

PMID 37193479

Authors

Raghad O Alkhaldi

Huda A Alzahrani

Lobna A Metwally

Affiliations

Soon will be listed here.

Abstract

Background In this study, we aimed to evaluate the knowledge and awareness about cervical cancer, human papillomavirus (HPV) and its vaccine among women living in the western region of Saudi Arabia. Methodology Using a cross-sectional online survey, this study assesses the knowledge and awareness level of HPV and the risk factors of cervical cancer among women living in the western region of Saudi Arabia. The design of the questionnaire is based on several earlier studies in different populations. Results The total completed responses include a sample of 624 that was subjected to statistical analysis; the analysis showed that only 34.6% were aware of HPV. Participants who belonged to the 21-30 and 31-40-year-old groups had comparatively more awareness than other age groups (p<0.001). Most (83.8%) believed that it would cause cervical cancer. Less than half (45.8%) knew that there is a vaccine against HPV infection. When we assessed the willingness to receive the vaccine, it was found that 75.8% were willing to take it. Conclusions The study found that women in the western region of Saudi Arabia have limited knowledge of cervical cancer and HPV and its vaccine. There is a need to educate and promote awareness of HPV and its complications for women in the western region of Saudi Arabia.

Citing Articles

Knowledge and Attitudes Regarding Human Papillomavirus Vaccination Among Future Healthcare Workers in Serbia.

Maletin N, Denda N, Ljubicic A, Velicki R, Patic A, Golusin Z Vaccines (Basel). 2025; 13(1).

PMID: 39852791 PMC: 11768562. DOI: 10.3390/vaccines13010011.

Study of the Prevalence of Human Papillomavirus Genotypes in Jeddah, Saudi Arabia.

El-Daly M, Faizo A, Madkhali S, Aldardeir N, Badroon N, Uthman N J Epidemiol Glob Health. 2025; 15(1):1.

PMID: 39808221 PMC: 11732795. DOI: 10.1007/s44197-025-00340-x.

Awareness and acceptance of human papillomavirus vaccine in the Middle East: A systematic review, meta-analysis, and meta-regression of 159 studies.

Gulle B, Kiran P, Celik S, Varol Z, Siyve N, Emecen A Epidemiol Infect. 2024; 152:e165.

PMID: 39655623 PMC: 11696605. DOI: 10.1017/S0950268824001596.

Advances and challenges in the use of liquid biopsy in gynaecological oncology.

Zhang Y, Tian L Heliyon. 2024; 10(20):e39148.

PMID: 39492906 PMC: 11530831. DOI: 10.1016/j.heliyon.2024.e39148.

Influence of RNA Methylation on Cancerous Cells: A Prospective Approach for Alteration of In Vivo Cellular Composition.

Rupareliya M, Shende P Adv Exp Med Biol. 2024; 1474():79-103.

PMID: 39259424 DOI: 10.1007/5584_2024_820.

References

Hussain A, Alkhenizan A, McWalter P, Qazi N, Alshmassi A, Farooqi S . Attitudes and perceptions towards HPV vaccination among young women in Saudi Arabia. J Family Community Med. 2016; 23(3):145-50. PMC: 5009883. DOI: 10.4103/2230-8229.189107. View

Turki R, Sait K, Anfinan N, Sohrab S, Abuzenadah A . Prevalence of human papillomavirus in women from Saudi Arabia. Asian Pac J Cancer Prev. 2013; 14(5):3177-81. DOI: 10.7314/apjcp.2013.14.5.3177. View

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

Story H, Love R, Salim R, Roberto A, Krieger J, Ginsburg O . Improving outcomes from breast cancer in a low-income country: lessons from bangladesh. Int J Breast Cancer. 2012; 2012:423562. PMC: 3262600. DOI: 10.1155/2012/423562. View

Sankaranarayanan R, Nene B, Shastri S, Jayant K, Muwonge R, Budukh A . HPV screening for cervical cancer in rural India. N Engl J Med. 2009; 360(14):1385-94. DOI: 10.1056/NEJMoa0808516. View

Peirson L, Fitzpatrick-Lewis D, Ciliska D, Warren R . Screening for cervical cancer: a systematic review and meta-analysis. Syst Rev. 2013; 2:35. PMC: 3681632. DOI: 10.1186/2046-4053-2-35. View

Manji M . Cervical cancer screening program in Saudi Arabia: action is overdue. Ann Saudi Med. 2007; 20(5-6):355-7. DOI: 10.5144/0256-4947.2000.355. View

Liu Z, Nyitray A, Hwang L, Swartz M, Abrahamsen M, Lazcano-Ponce E . Acquisition, Persistence, and Clearance of Human Papillomavirus Infection Among Male Virgins Residing in Brazil, Mexico, and the United States. J Infect Dis. 2017; 217(5):767-776. PMC: 5853496. DOI: 10.1093/infdis/jix588. View

Sait K . Attitudes, knowledge, and practices in relation to cervical cancer and its screening among women in Saudi Arabia. Saudi Med J. 2009; 30(9):1208-12. View

10.

Alsous M, Ali A, Al-Azzam S, Abdel Jalil M, Al-Obaidi H, Al-Abbadi E . Knowledge and awareness about human papillomavirus infection and its vaccination among women in Arab communities. Sci Rep. 2021; 11(1):786. PMC: 7804285. DOI: 10.1038/s41598-020-80834-9. View

11.

Johnson D, Bhatta M, Gurung S, Aryal S, Lhaki P, Shrestha S . Knowledge and awareness of human papillomavirus (HPV), cervical cancer and HPV vaccine among women in two distinct Nepali communities. Asian Pac J Cancer Prev. 2014; 15(19):8287-93. DOI: 10.7314/apjcp.2014.15.19.8287. View

12.

Doorbar J, Quint W, Banks L, Bravo I, Stoler M, Broker T . The biology and life-cycle of human papillomaviruses. Vaccine. 2012; 30 Suppl 5:F55-70. DOI: 10.1016/j.vaccine.2012.06.083. View

13.

Tota J, Chevarie-Davis M, Richardson L, deVries M, Franco E . Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies. Prev Med. 2011; 53 Suppl 1:S12-21. DOI: 10.1016/j.ypmed.2011.08.017. View

14.

Hopfer S, Wright M, Pellman H, Wasserman R, Fiks A . HPV vaccine recommendation profiles among a national network of pediatric practitioners: understanding contributors to parental vaccine hesitancy and acceptance. Hum Vaccin Immunother. 2018; 15(7-8):1776-1783. PMC: 6746469. DOI: 10.1080/21645515.2018.1560771. View

15.

Alobaid A, Al-Badawi I, Al-Kadri H, Gopala K, Kandeil W, Quint W . Human papillomavirus prevalence and type distribution among women attending routine gynecological examinations in Saudi Arabia. BMC Infect Dis. 2014; 14:643. PMC: 4272558. DOI: 10.1186/s12879-014-0643-8. View

16.

Arbyn M, Xu L, Simoens C, Martin-Hirsch P . Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev. 2018; 5:CD009069. PMC: 6494566. DOI: 10.1002/14651858.CD009069.pub3. View

17.

Reid R, Stanhope C, Herschman B, Booth E, Phibbs G, Smith J . Genital warts and cervical cancer. I. Evidence of an association between subclinical papillomavirus infection and cervical malignancy. Cancer. 1982; 50(2):377-87. DOI: 10.1002/1097-0142(19820715)50:2<377::aid-cncr2820500236>3.0.co;2-a. View

18.

Aynalem B, Anteneh K, Enyew M . Utilization of cervical cancer screening and associated factors among women in Debremarkos town, Amhara region, Northwest Ethiopia: Community based cross-sectional study. PLoS One. 2020; 15(4):e0231307. PMC: 7138328. DOI: 10.1371/journal.pone.0231307. View

19.

. Human papillomavirus vaccines: WHO position paper, May 2017-Recommendations. Vaccine. 2017; 35(43):5753-5755. DOI: 10.1016/j.vaccine.2017.05.069. View

20.

Meites E, Szilagyi P, Chesson H, Unger E, Romero J, Markowitz L . Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2019; 68(32):698-702. PMC: 6818701. DOI: 10.15585/mmwr.mm6832a3. View